The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Combination Therapy with Clindamycin and Rifampicin for Hidradenitis Suppurativa: A Series of 116 Consecutive Patients
Abstract
Background: Antibiotics are frequently used to treat hidradenitis suppurativa (HS); however, few data on their efficacy are available. Objective: To evaluate the efficacy of a combination of systemic clindamycin (300 mg twice daily) and rifampicin (600 mg daily) in the treatment of patients with severe HS. Methods: Patients (n = 116) who received this combination were studied retrospectively. The main outcome measure was the severity of the disease, assessed by the Sartorius score, before and after 10 weeks of treatment. Results: The Sartorius score dramatically improved at the end of treatment (median = 29, interquartile range = 14.5, vs. median = 14.5, interquartile range = 11; p < 0.001), as did other parameters of severity as well as the quality of life score. Eight patients (6.9%) stopped the treatment because of side effects. Conclusion: The combination of clindamycin and rifampicin is effective in the treatment of severe HS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revuz, J. E., Canoui-Poitrine, F., Wolkenstein, P., Viallette, C., Gabison, G., Pouget, F., Poli, F., Faye, O., Roujeau, J. C., Bonnelye, G., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.06.020 · Cited by 627
Self-citationThe prevalence of hidradenitis suppurativa and its potential precursor lesions
Jemec, G. B. E., Heidenheim, M., & Nielsen, N. H. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90321-7 · Cited by 508
Quality of life impairment in hidradenitis suppurativa: A study of 61 cases
Wolkenstein, P., Loundou, A., Barrau, K., Auquier, P., & Revuz, J. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.061 · Cited by 369
Self-citationMorbidity in patients with hidradenitis suppurativa
Von Der Werth, J. M., & Jemec, G. B. E. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04137.x · Cited by 344
Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa
Jemec, G. B. E., & Wendelboe, P. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70272-5 · Cited by 338
Canoui-Poitrine, F., Revuz, J. E., Wolkenstein, P., Viallette, C., Gabison, G., Pouget, F., Poli, F., Faye, O., & Bastuji-Garin, S. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.02.013 · Cited by 301
Self-citationTopical Treatment of Hidradenitis Suppurativa with Clindamycin
Clemmensen, O. J. (1983) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1983.tb02150.x · Cited by 270
Sartorius, K., Lapins, J., Emtestam, L., & Jemec, G. B. E. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05390.x · Cited by 252
van der Zee, H. H., Boer, J., Prens, E. P., & Jemec, G. B. E. (2009) · Dermatology · doi:10.1159/000228337 · Cited by 222
Mendonça, C. O., & Griffiths, C. E. M. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07155.x · Cited by 219
Lincomycin, clindamycin and their applications
Spížek, J., & Řezanka, T. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1545-7 · Cited by 204
LAPINS, JARSTRAND, & EMTESTAM (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02613.x · Cited by 173
Cusack, C., & Buckley, C. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07067.x · Cited by 171
Clindamycin-Induced Suppression of Toxic-Shock Syndrome-Associated Exotoxin Production
Schlievert, P. M., & Kelly, J. A. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/149.3.471 · Cited by 162
The Bacteriology of Hidradenitis suppurativa
Jemec, G. B. E., Faber, M., Gutschik, E., & Wendelboe, P. (1996) · Dermatology · doi:10.1159/000246246 · Cited by 159
Infliximab for hidradenitis suppurativa
Sullivan, T. P., Welsh, E., Kerdel, F. A., Burdick, A. E., & Kirsner, R. S. (2003) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2003.05663.x · Cited by 158
Hidradenitis suppurativa - characteristics and consequences
Jemec, G. B. E., Heidenheim, M., & Nielsen, N. H. (1996) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1996.tb00145.x · Cited by 145
Fardet, L., Dupuy, A., Kérob, D., Levy, A., Allez, M., Bégon, E., Bachelez, H., Morel, P., & Lebbé, C. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.027 · Cited by 128
Giamarellos‐Bourboulis, E. J., Pelekanou, E., Antonopoulou, A., et al. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08372.x · Cited by 124
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa
Mekkes, J. R., & Bos, J. D. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08332.x · Cited by 105
Aerobic and anaerobic microbiology of axillary hidradenitis suppurativa
Brook, I., & Frazier, E. H. (1999) · Journal of Medical Microbiology · doi:10.1099/00222615-48-1-103 · Cited by 81
Leach, R. D., Eykyn, S. J., Phillips, I., CORRIN, B., & Taylor, E. (1979) · BMJ · doi:10.1136/bmj.2.6181.5 · Cited by 62
Long-term infliximab for severe hidradenitis suppurativa
Thielen, A. M., Barde, C., & Saurat, J. ‐. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07528.x · Cited by 57
Moschella, S. L. (2007) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2007.03293.x · Cited by 53
Infliximab for the Treatment of Hidradenitis Suppurativa
Fernández-Vozmediano, J. M., & Armario-Hita, J. C. (2007) · Dermatology · doi:10.1159/000102032 · Cited by 47
Revuz, J. E. (2007) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(07)91613-0 · Cited by 41
Self-citationTsankov, N., & Angelova, I. (2003) · Clinics in Dermatology · doi:10.1016/s0738-081x(02)00328-0 · Cited by 35
Spisani, S., Traniello, S., Martuccio, C., Rizzuti, O., & Cellai, L. (1997) · Inflammation · doi:10.1023/a:1027314419843 · Cited by 29
Yerramasetti, R., Gollapudi, S. V. S., & Gupta, S. (2002) · Journal of Clinical Immunology · doi:10.1023/a:1014256603539 · Cited by 23
Bacteriology of Hidradenitis Suppurativa
Oprica, C., & Nord, C. E. (2006) · Springer eBooks · doi:10.1007/978-3-540-33101-8_11 · Cited by 15
Cited by
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Zouboulis, C. C., Desai, N., Emtestam, L., Hunger, R. E., Ioannides, D., Juhász, I., Lapins, J., Matusiak, L., Prens, E. P., Revuz, J., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12966 · Cited by 1,093
Self-citationJemec, G. B. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmcp1014163 · Cited by 817
Alikhan, A., Sayed, C., Alavi, A., Alhusayen, R., Brassard, A., Burkhart, C., Crowell, K., Eisen, D. B., Gottlieb, A. B., Hamzavi, I., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.02.067 · Cited by 400
Alikhan, A., Sayed, C., Alavi, A., Alhusayen, R., Brassard, A., Burkhart, C., Crowell, K., Eisen, D. B., Gottlieb, A. B., Hamzavi, I., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.02.068 · Cited by 399
Revuz, J. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03356.x · Cited by 336
Self-citation
Metadata
- Authors
- Gener, G., Canoui-Poitrine, F., Revuz, J. E., Faye, O., Poli, F., Gabison, G., Pouget, F., Viallette, C., Wolkenstein, P., & Bastuji-Garin, S.
- Venue
- Dermatology
- Publisher
- S. Karger AG
- Published
- 2009
- Volume
- 219
- Issue
- 2
- Pages
- 148-154
- ISSN
- 1018-8665 (ISSN-L)
- 1421-9832
- OpenAlex
- W2091225905
- Cited by
- 265
- References
- 30
- FWCI
- 12.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.